INMD

Inmode Ltd

Add to Watchlist

Advanced Chart

14.540

-0.18(-1.223%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

14.755

Open

14.690

VWAP

Vol

761.86K

Mkt Cap

919.06M

Low

14.525

Amount

EV/EBITDA(TTM)

3.77

Total Shares

84.62M

417.51M

EV/OCF(TTM)

3.41

P/S(TTM)

2.88

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

105.08M

+7.38%

0.514

+22.33%

86.79M

-33.35%

0.376

-46.35%

94.22M

+8.98%

0.407

+19.6%

Estimates Revision

The market is revising Downward the revenue expectations for InMode Ltd. (INMD) for FY2025, with the revenue forecasts being adjusted by -5.93% over the past three months. During the same period, the stock price has changed by 0.83%.

Revenue Estimates for FY2025

Revise Downward

-5.93%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-1.73%

In Past 3 Month

Stock Price

Go Up

+0.83%

In Past 3 Month

6 Analyst Rating

22.49% Upside

Wall Street analysts forecast INMD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INMD is 17.81 USD with a low forecast of 15.00 USD and a high forecast of 24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

5 Hold

0 Sell

Hold

22.49% Upside

Current: 14.540

Low

15.00

Averages

17.81

High

24.00

22.49% Upside

Current: 14.540

Low

15.00

Averages

17.81

High

24.00

Needham

Mike Matson

Hold

Reiterates

n/a

2025-04-14

Reason

Needham

Mike Matson

Price Target

n/a

2025-04-14

Reiterates

Hold

Reason

Jefferies

Matthew Taylor

Hold

Maintains

$16 → $15

2025-04-14

Reason

Jefferies

Matthew Taylor

Price Target

$16 → $15

2025-04-14

Maintains

Hold

Reason

Needham

Mike Matson

Hold

Reiterates

n/a

2025-04-09

Reason

Needham

Mike Matson

Price Target

n/a

2025-04-09

Reiterates

Hold

Reason

Barclays

Matt Miksic

Buy

Maintains

$26 → $29

2025-02-05

Reason

Barclays

Matt Miksic

Price Target

$26 → $29

2025-02-05

Maintains

Buy

Reason

Needham

Mike Matson

Hold

Maintains

n/a

2025-02-04

Reason

Needham

Mike Matson

Price Target

n/a

2025-02-04

Maintains

Hold

Reason

Barclays

Matt Miksic

Buy

Maintains

$27 → $26

2025-01-09

Reason

Barclays

Matt Miksic

Price Target

$27 → $26

2025-01-09

Maintains

Buy

Reason

Barclays lowered the firm's price target on InMode to $26 from $27 and keeps an Overweight rating on the shares. After ramping production of new products to meet demand in Q3, InMode cited slower demand in Q4, reducing sales outlook for 2024 by about $23M and setting initial 2025 guidance below consensus, the analyst tells investors in a research note. The firm cut its estimates and price target, but reiterated its Overweight rating, which assumes that demand begins to improve in 2025.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Inmode Ltd (INMD.O) is 8.77, compared to its 5-year average forward P/E of 15.62. For a more detailed relative valuation and DCF analysis to assess Inmode Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

15.62

Current PE

8.77

Overvalued PE

24.02

Undervalued PE

7.23

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued

5Y Average EV/EBITDA

11.19

Current EV/EBITDA

4.06

Overvalued EV/EBITDA

18.13

Undervalued EV/EBITDA

4.25

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

6.02

Current PS

2.52

Overvalued PS

9.20

Undervalued PS

2.84

Financials

Annual

Quarterly

FY2025Q1

YoY :

-3.00%

77.87M

Total Revenue

FY2025Q1

YoY :

-13.67%

15.62M

Operating Profit

FY2025Q1

YoY :

-23.19%

18.20M

Net Income after Tax

FY2025Q1

YoY :

-7.14%

0.26

EPS - Diluted

FY2025Q1

YoY :

-41.84%

13.96M

Free Cash Flow

FY2025Q1

YoY :

-1.76%

78.22

Gross Profit Margin - %

FY2025Q1

YoY :

-19.21%

31.08

FCF Margin - %

FY2025Q1

YoY :

-20.83%

23.37

Net Margin - %

FY2025Q1

YoY :

-4.07%

24.50

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

7.1K

Volume

6-9

Months

504.4K

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

67.8K

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

INMD News & Events

Events Timeline

2025-07-10 (ET)

2025-07-10

07:06:18

InMode cut FY25 revenue guidance $365M-$375M from $395M-$405M

2025-07-10

07:05:41

InMode sees Q2 revenue $95.4M-$95.5M, consensus $98.45M

2025-05-09 (ET)

2025-05-09

08:24:32

DOMA Perpetual urges InMode board to resume share repurchases, replace CEO

News

7.0

07-10NASDAQ.COM

InMode Lowers FY25 Revenue Guidance

9.5

07-10PRnewswire

InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M

6.5

06-20NASDAQ.COM

The Implied Analyst 12-Month Target For ESGV